Trials / Terminated
TerminatedNCT02153593
Postoperative Bleeding Prevention in Massive Bone Tumour Resection
Postoperative Bleeding Prevention in Massive Bone Tumour Resection: a Multicentric, Randomized, Parallel, Controlled Trial to Assess the Efficacy of Tranexamic Acid Versus Evicel® and Usual Haemostasis
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Massive bone tumour resection is often associated with important postoperative bleeding. This may determine systemic (anaemia), as well as local complications (wound healing, seroma, haematoma). The objective of this study is to determine whether the use of topical tranexamic acid or topical Evicel® will reduce the perioperative bleeding comparing it with usual haemostasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid | 1g intra-articular before closing the wound surgery |
| DRUG | Fibrin glue | 5mL intra-articular before closing the wound surgery |
| PROCEDURE | Electrocauterization | Coagulation blood from vessels by means of a electrocautery |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-03-01
- Completion
- 2015-05-01
- First posted
- 2014-06-03
- Last updated
- 2016-09-20
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02153593. Inclusion in this directory is not an endorsement.